Opiant Pharmaceuticals Stock

Opiant Pharmaceuticals EBIT Margin

Delisted

The EBIT Margin (Operating Margin) of Opiant Pharmaceuticals (OPNT) as of Aug 22, 2026 is 10.79 %. In the previous year, EBIT Margin (Operating Margin) was -7.56 % — a change of -242.73% (higher).

EBIT Margin

10.79 %

YoY

-242.73%

Last updated:

EBIT Margin (Operating Margin) of Opiant Pharmaceuticals is 2026 10.79 % . EBIT Margin (Operating Margin) of Opiant Pharmaceuticals was 2025 -7.56 % . It decreases by -242.73% higher compared to the previous year.

Opiant Pharmaceuticals's operating (EBIT) margin stands at 10.8%, down from 13.1% several years earlier.

Access this data via the Eulerpool API

Opiant Pharmaceuticals Stock analysis

What does Opiant Pharmaceuticals do? Opiant Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of medications for the treatment of addiction disorders and acute medical needs. The company was founded in 2006 and is headquartered in Santa Monica, California. Since its inception, Opiant Pharmaceuticals Inc. has developed innovative drugs that can help mitigate the effects of addiction disorders and meet the demand for emergency medications. The company follows a clear business model based on the implementation of clinical trials and the commercialization of the resulting medications. One of Opiant Pharmaceuticals Inc.'s core areas is the development of medications that can be used in the context of opioid overdoses. One of the best-known products is Narcan Nasal Spray, an emergency medication that can be used in cases of opioid overdose. The product is fast, easy, and safe to use and has proven to be highly effective in practice. In addition to the development of medications for the treatment of opioid overdoses, Opiant Pharmaceuticals Inc. has also developed medications for the treatment of alcohol dependence. One of the best-known medications is Nalmefene, sold as Selincro in Europe and Canada. The medication is used in combination with behavioral counseling and has proven to be an effective treatment option for patients with alcohol dependence. Another division of Opiant Pharmaceuticals Inc. is the development of medications for acute medical needs. This includes medications such as Fentanyl Nasal Spray, which can be used for the treatment of acute pain. Another medication is the opioid analgesic Oxycodone combined with Naltrexone, which is used for the treatment of moderate to severe pain. In addition, Opiant Pharmaceuticals Inc. also has a wide range of products in the pipeline that are in various stages of development and clinical trials. These include medications for the treatment of methamphetamine and cocaine dependence, as well as for postoperative nausea and vomiting. The company actively invests in research and development and is constantly striving to develop innovative and effective medications that can help minimize the effects of addiction disorders and meet medical needs. Overall, Opiant Pharmaceuticals Inc. has established itself as a leading provider of medications for the treatment of addiction disorders. The company has an impressive track record in drug development and aims to offer effective treatment options to patients around the world. With a strong pipeline of products and a dedicated leadership team, Opiant Pharmaceuticals Inc. is well-positioned to continue growing in the coming years and establish itself as a leading provider of medications for the treatment of addiction disorders. Opiant Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Opiant Pharmaceuticals stock

EBIT Margin (Operating Margin) of Opiant Pharmaceuticals is 10.79 % in 2026.

EBIT Margin (Operating Margin) of Opiant Pharmaceuticals changed from -7.56 % to 10.79 %, representing a -242.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Opiant Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Opiant Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Opiant Pharmaceuticals

All Key Metrics — Opiant Pharmaceuticals